Intracel OncoVAX Phase III Will Follow Patients For Three Years
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm says single pivotal trial of the autologous cancer vaccine can support a BLA for adjuvant treatment of Stage II colon cancer.